Stem cell therapies are changing lives around the world
The Division of Immunotherapy and Autoimmune Diseases (DIAD) is the only center in the world devoted to a unique area of treatment and research utilizing stem cell transplantation in clinical trials for autoimmune diseases and vascular diseases. DIAD pioneered and performed America’s first hematopoietic stem cell transplants to treat: Multiple Sclerosis (MS), Diabetes, Lupus, Crohn’s, Rheumatoid Arthritis, Chronic Inflammatory Demyelinating Polyneuropathy (CIDP), Phemphigus, Dermatomyositis, Devic’s, Myasthenia Gravis, Polymositis and Scleroderma.

Immunotherapy “Ceasefire”for Autoimmune DiseasesAutoimmune diseases result from misdirected immune systems that begin to attack, rather than protect, tissues in the body. Immunotherapy delivers a “ceasefire” with the stem cell transplant approach to suppress the immune system and eliminate the immune cells causing the progression of the disease. LEARN MORE >

“Turning the Tide on MS”
“This is the first time in history, of any therapy used to treat MS, where it actually reverses neurological deficit, allowing us to turn the tide of the disease,” said Dr. Richard K. Burt, the pioneer of stem cell research.LEARN MORE ABOUT THE APPROVED RANDOMIZED MS TRIAL >